Avellino Lab USA has announced additional production shifts to scale up the manufacturing of the SARS-CoV-2/COVID-19 Test (AvellinoCoV2), its newly developed coronavirus (Covid-19) diagnostic.
This ultra-rapid genetic test helps clinicians diagnose Covid-19 caused by a SARS-CoV-2 virus infection by identifying and isolating the genetic markers as approved by the FDA and the CDC.
The test is considered to be in high demand among health systems, public health services and first-responders due its precision, speed and ability to detect the disease in asymptomatic patients.
